{"transactions":[{"id":1543563,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-04-11T01:52:02.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The awards were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":147094,"derivative":{"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001683168-24-002287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824002287/ownership.xml","form_type":"4"}},{"id":1543562,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-04-11T01:52:02.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The awards were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":129594,"derivative":{"exercise_price":0.2586,"expiration_date":"2034-04-08","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001683168-24-002287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824002287/ownership.xml","form_type":"4"}},{"id":1656408,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrant to purchase common stock","published_at":"2024-02-06T15:27:56.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024."}],"balance_after":112094,"derivative":{"exercise_price":0.3,"exercise_date":"2024-02-01","expiration_date":"2025-10-01","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001683168-24-000707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824000707/ownership.xml","form_type":"4"}},{"id":1656407,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrant to purchase common stock","published_at":"2024-02-06T15:27:56.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024."}],"balance_after":78761,"derivative":{"exercise_price":0.3,"exercise_date":"2024-02-01","expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001683168-24-000707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824000707/ownership.xml","form_type":"4"}},{"id":1656406,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-02-06T15:27:56.000Z","date":"2024-02-01","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":0.3,"value":9999.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024."}],"balance_after":33458,"source":{"system":"sec-edgar","filing":"0001683168-24-000707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316824000707/ownership.xml","form_type":"4"}},{"id":1760961,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-10-12T22:01:15.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":39475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":45428,"derivative":{"exercise_price":1.09,"expiration_date":"2033-09-22","underlying":"Common Stock","underlying_shares":39475},"source":{"system":"sec-edgar","filing":"0001683168-23-007110","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823007110/ownership.xml","form_type":"4/A","original_submission_date":"2023-09-25"}},{"id":1773748,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-09-25T22:24:59.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":68961,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":74914,"derivative":{"exercise_price":1.09,"expiration_date":"2033-09-22","underlying":"Common Stock","underlying_shares":68961},"source":{"system":"sec-edgar","filing":"0001683168-23-006682","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823006682/ownership.xml","form_type":"4"}},{"id":2341008,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T19:34:18.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":3750,"price":0.268,"value":1005.0,"ownership":{"direct":true},"balance_after":3750,"source":{"system":"sec-edgar","filing":"0001683168-22-001545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316822001545/ownership.xml","form_type":"4"}},{"id":2631563,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-07-16T21:00:28.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":32000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date hereof or the date of the 2022 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":178559,"derivative":{"exercise_price":1.8,"expiration_date":"2031-07-15","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001683168-21-002998","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316821002998/ownership.xml","form_type":"4"}},{"id":3108296,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":92076,"kind":"person","name":"Evans Carl Anthony","position":1,"cik":"0001792582","reported_name":"Evans Carl Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-06-16T21:23:08.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":46559,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":146559,"derivative":{"exercise_price":2.47,"expiration_date":"2030-06-12","underlying":"Common Stock","underlying_shares":46559},"source":{"system":"sec-edgar","filing":"0001683168-20-001966","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316820001966/ownership.xml","form_type":"4"}}]}